tiprankstipranks
Trending News
More News >
Invex Therapeutics Ltd. (AU:IXC)
ASX:IXC
Australian Market
Advertisement

Invex Therapeutics Ltd. (IXC) Financial Statements

Compare
2 Followers

Invex Therapeutics Ltd. Financial Overview

Invex Therapeutics Ltd.'s market cap is currently AU$6.76M. The company's EPS TTM is AU$0.001; its P/E ratio is 58.67; Invex Therapeutics Ltd. is scheduled to report earnings on February 13, 2025, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Jun 23Jun 22Jun 21Jun 20
Income Statement
Total RevenueAU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00AU$ 0.00
Gross ProfitAU$ 1.21MAU$ 459.08KAU$ 182.25KAU$ 0.00AU$ 0.00
Operating IncomeAU$ -2.13MAU$ -8.55MAU$ -4.03MAU$ -2.44MAU$ -3.25M
EBITDAAU$ -720.00KAU$ 0.00AU$ -4.24MAU$ -2.44MAU$ -3.29M
Net IncomeAU$ -1.64MAU$ -7.75MAU$ -3.95MAU$ -2.28MAU$ -3.36M
Balance Sheet
Cash & Short-Term InvestmentsAU$ 6.03MAU$ 22.47MAU$ 29.34MAU$ 32.72MAU$ 26.30M
Total AssetsAU$ 6.12MAU$ 22.80MAU$ 29.49MAU$ 32.74MAU$ 26.42M
Total DebtAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Net DebtAU$ -6.03MAU$ -22.47MAU$ -29.34MAU$ -32.72MAU$ -26.30M
Total LiabilitiesAU$ 431.63KAU$ 1.57MAU$ 1.00MAU$ 658.61KAU$ 2.02M
Stockholders' EquityAU$ 5.69MAU$ 21.23MAU$ 28.48MAU$ 32.08MAU$ 24.40M
Cash Flow
Free Cash FlowAU$ -2.44MAU$ -6.87MAU$ -3.38MAU$ -1.68MAU$ -1.60M
Operating Cash FlowAU$ -2.44MAU$ -6.87MAU$ -3.38MAU$ -1.68MAU$ -1.60M
Investing Cash FlowAU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00AU$ 0.00
Financing Cash FlowAU$ -14.00MAU$ 0.00AU$ 0.00AU$ 8.09MAU$ 15.73M
Currency in AUD

Invex Therapeutics Ltd. Earnings and Revenue History

Invex Therapeutics Ltd. Debt to Assets

Invex Therapeutics Ltd. Cash Flow

Invex Therapeutics Ltd. Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis